Stock Comparison
RPRX vs VRTX
Royalty Pharma Plc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$33.14B
$123.94B
P/E (TTM)
30.8
28.5
Forward P/E
47.4
25.7
Price/Sales
13.1
9.9
Price/Book
3.7
6.1
EV/EBITDA
33.5
23.2
Dividend Yield
1.55%
—
Profitability
Net Margin
32.15%
35.40%
Operating Margin
62.34%
38.97%
Return on Equity
14.00%
23.50%
Return on Assets
5.09%
11.90%
Growth (YoY)
Revenue Growth
16.50%
12.50%
Earnings Growth
-46.30%
8.00%
Price & Risk
Beta
0.4
0.3
52-Week High
$59.97
$529.65
52-Week Low
$34.37
$376.62
Analyst Target
$63.75
$559.28
Compare RPRX and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.